Sandy Lucier

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Stanislas Pol, Marc Bourlière, Sandy Lucier et al. · Journal of Hepatology · 2016 · 126 citations · Full text

Viral Hepatitis, Antiviral Therapy, Hepatitis +5

LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*

S. Pol, Marc Bourlière, Sandy Lucier et al. · Journal of Hepatology · 2015 · 36 citations

Viral Hepatitis, Antiviral Therapy, Hepatitis +6

Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort

Karine Chevreul, G. Haour, Sandy Lucier et al. · PLoS ONE · 2014 · 28 citations · Full text

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

Hélène Fontaine, Christophe Hézode, Fabien Zoulim et al. · Journal of Hepatology · 2015 · 22 citations

Viral Hepatitis, Immunology, Antiviral Therapy +8

Work Productivity Loss in Early Arthritis During the First 3 Years of Disease: A Study From a French National Multicenter Cohort

Sabrina Dadoun, Françis Guillemin, Sandy Lucier et al. · Arthritis Care & Research · 2014 · 10 citations